Myeloproliferative neoplasm: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
m (Bot: Removing from Primary care)
 
(14 intermediate revisions by 6 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{DiseaseDisorder infobox |
{{Myeloproliferative neoplasm}}
  Name          = {{PAGENAME}} |
{{CMG}}{{AE}} {{MJK}} {{shyam}}
  Image          = |
  Caption        = |
  ICD10          = {{ICD10|D|47|1|d|37}} |
  ICD9          = {{ICD9|205.1}}, {{ICD9|238.4}}, {{ICD9|289.89}}, {{ICD9|289.9}} |
  ICDO          = |
  OMIM          = |
  DiseasesDB    = |
  MedlinePlus    = |
  eMedicineSubj  = |
  eMedicineTopic = |
  MeshID        = D009196 |
}}
{{Myeloproliferative disease}}
{{CMG}}


{{SK}} Myeloproliferation, myeloproliferative disorder, myeloproliferative neoplasm
{{SK}} MPN; Myeloproliferative disease; Myeloproliferative disorder; Myeloproliferation


==[[Myeloproliferative disease overview|Overview]]==
==[[Myeloproliferative neoplasm overview|Overview]]==


==[[Myeloproliferative disease historical perspective|Historical Perspective]]==
==[[Myeloproliferative neoplasm historical perspective|Historical Perspective]]==


==[[Myeloproliferative disease classification|Classification]]==
==[[Myeloproliferative neoplasm classification|Classification]]==


==[[Myeloproliferative disease pathophysiology|Pathophysiology]]==
==[[Myeloproliferative neoplasm pathophysiology|Pathophysiology]]==


==[[Myeloproliferative disease causes|Causes]]==
==[[Myeloproliferative neoplasm causes|Causes]]==


==[[Myeloproliferative disease differential diagnosis|Differentiating Myeloproliferative disease from other Diseases]]==
==[[Myeloproliferative neoplasm differential diagnosis|Differentiating myeloproliferative neoplasm from other Diseases]]==


==[[Myeloproliferative disease epidemiology and demographics|Epidemiology and Demographics]]==
==[[Myeloproliferative neoplasm epidemiology and demographics|Epidemiology and Demographics]]==


==[[Myeloproliferative disease risk factors|Risk Factors]]==
==[[Myeloproliferative neoplasm risk factors|Risk Factors]]==


==[[Myeloproliferative neoplasm screening|Screening]]==


 
==[[Myeloproliferative neoplasm natural history, complications, and prognosis|Natural History, Complications, and Prognosis]]==
==[[Myeloproliferative disease screening|Screening]]==
 
==[[Myeloproliferative disease natural history, complications and prognosis|Natural History, Complications and Prognosis]]==


==Diagnosis==
==Diagnosis==
[[Myeloproliferative disease history and symptoms| History and Symptoms]] | [[Myeloproliferative disease physical examination | Physical Examination]] | [[Myeloproliferative disease laboratory findings|Laboratory Findings]] | [[Myeloproliferative disease chest x ray|Chest X Ray]] |  [[Myeloproliferative disease CT|CT]] | [[Myeloproliferative disease MRI|MRI]] | [[Myeloproliferative disease ultrasound|Ultrasound]] | [[Myeloproliferative disease other imaging findings|Other Imaging Findings]] | [[Myeloproliferative disease other diagnostic studies|Other Diagnostic Studies]]
[[Myeloproliferative neoplasm diagnostic study of choice|Diagnostic study of choice]] | [[Myeloproliferative neoplasm history and symptoms|History and Symptoms]] | [[Myeloproliferative neoplasm physical examination|Physical Examination]] | [[Myeloproliferative neoplasm laboratory findings|Laboratory Findings]] | [[Myeloproliferative neoplasm chest x ray|Chest X Ray]] |  [[Myeloproliferative neoplasm CT|CT]] | [[Myeloproliferative neoplasm MRI|MRI]] | [[Myeloproliferative neoplasm ultrasound|Ultrasound]] | [[Myeloproliferative neoplasm other imaging findings|Other Imaging Findings]] | [[Myeloproliferative neoplasm other diagnostic studies|Other Diagnostic Studies]]


==Treatment==
==Treatment==
[[Myeloproliferative disease medical therapy|Medical Therapy]] | [[Myeloproliferative disease surgery|Surgery]] | [[Myeloproliferative disease primary prevention|Primary Prevention]] | [[Myeloproliferative disease secondary prevention|Secondary Prevention]] | [[Myeloproliferative disease cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Myeloproliferative disease future or investigational therapies|Future or Investigational Therapies]]
[[Myeloproliferative neoplasm medical therapy|Medical Therapy]] | [[Myeloproliferative neoplasm surgery|Surgery]] | [[Myeloproliferative neoplasm primary prevention|Primary Prevention]] | [[Myeloproliferative neoplasm secondary prevention|Secondary Prevention]] | [[Myeloproliferative neoplasm cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Myeloproliferative neoplasm future or investigational therapies|Future or Investigational Therapies]]


==Case Studies==
==Case Studies==
[[Myeloproliferative disease case study one|Case #1]]  
[[Myeloproliferative neoplasm case study one|Case #1]]
 
{{Hematology}}
{{Hematological malignancy histology}}


[[Category:Medicine]]
[[Category:Hematology]]
[[Category:Hematology]]
[[Category:Disease]]
[[Category:Oncology]]
 
[[Category:Up-To-Date]]
 
[[ar:مرض التكاثر النقوي]]
[[de:Myeloproliferative Erkrankung]]
[[es:Síndrome mieloproliferativo crónico]]
[[fr:Syndrome myéloprolifératif]]
[[pl:Zespoły mieloproliferacyjne]]
 
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Latest revision as of 22:50, 29 July 2020

Myeloproliferative Neoplasm Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating myeloproliferative neoplasm from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Myeloproliferative neoplasm On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Myeloproliferative neoplasm

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Myeloproliferative neoplasm

on Myeloproliferative neoplasm

Myeloproliferative neoplasm in the news

Blogs on Myeloproliferative neoplasm

Directions to Hospitals Treating Myeloproliferative neoplasm

Risk calculators and risk factors for Myeloproliferative neoplasm

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2] Shyam Patel [3]

Synonyms and keywords: MPN; Myeloproliferative disease; Myeloproliferative disorder; Myeloproliferation

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating myeloproliferative neoplasm from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

Diagnostic study of choice | History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1